```json
{
"content: [{"type":"paragraph","content":"Discovery Biology Service segmentation by application describes the therapeutic and diagnostic domains that contract research laboratories prioritize when allocating biology resources. Target Identification services account for the largest share because sponsors outsource high-throughage omics and CRISPR screening to optimize opportunity costs. Target Validation follows with gene knock-in/knock-out and biochemical assays that de-risk drugability questions before lead optimization. Pre-clinical Safety.\n\nThe Types taxonomy distinguishes Full-Service (pharma-scale, IP-free global platforms) from Standalone (modular, cost-efficient) and Hybrid (flex capacity) models. Full-Service providers command premium pricing but deliver greater economies of scale and regulatory compliance, making their share of market value larger than transaction volume. Standalone services facilitate incremental outsourcing, especially by emerging biotechs with limited internal wet-lab capacity. Hybrid models, often regionally focused, enable asset-based collaboration and are growing fastest as sponsors adopt functional-service-provider (FSP) strategies to mitigate cost escalation."}],"chartData":{"segments":[{"name":"Target Identification","value":37},{"name":"Target Validation","value":28},{"name":"Pre-clinical Safety","value":35}]},"_metadata":{"_billed_words":162}
```
